Delivery Order 36F79722D0090-36C24524N0738
Award Date
7/17/24
Potential Completion Date
8/23/24
Potential Value
$12K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Grifols USA LLC is for the delivery of PROLASTIN-C LIQUID, a 1000mg/vial alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The $499,680.00 firm fixed-price contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2024 by the Department of Veterans Affairs' Veterans Integrated Service Network 20. The contract is not set-aside and is issued under Grifols' Federal Supply Schedule (FSS-61-IB) contract for...
This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs (VA), to Grifols USA LLC. The $111,000.00 firm fixed-price contract is for the supply of PROLASTIN-C LIQUID, a plasma-derived alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract is part of Grifols' $1.38 billion Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs. The contract has a...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024. Grifols USA LLC holds a Federal...
This is a federal contract award to Grifols USA LLC, a global healthcare company, by the Veterans Integrated Service Network 23 (VISN 23), a division of the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, as well as other pharmaceutical supplies. The contract is a firm fixed-price delivery order with a ceiling value of $138,415.20 and an ultimate completion date of April 30,...
The U.S. Department of Veterans Affairs (VA) awarded a $100,800.00 Firm Fixed Price Delivery Order contract to Grifols USA LLC for the provision of PROLASTIN-C, an alpha1-proteinase inhibitor drug used to treat alpha1-antitrypsin deficiency. This contract is part of Grifols' $1.38 billion Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the VA. The contract has a period of performance through February 8, 2026 and was awarded without a set-aside designation,...
The Department of Veterans Affairs Veterans Health Administration awarded Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, a $130,406.43 delivery order contract for PROLASTIN 1000MG/VIAL. The contract is a firm fixed price agreement issued under the Pharmaceuticals and Drugs GSA Schedule. This award does not utilize a small business set-aside. Grifols has previously provided pharmaceutical products such as Prolastin, Prolastin-C, and...
The Department of Veterans Affairs Veterans Health Administration awarded a $109,200 delivery order contract to Grifols USA LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule. The contract calls for Grifols to provide PROLASTIN-C, a drug used to treat alpha-1 antitrypsin deficiency, to facilities located in Los Angeles, California. The base period of performance is one year, from February 8, 2024 through February 7, 2025. Pricing is firm fixed. No subcontractors or...
This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...
This federal contract award is a delivery order to Grifols USA LLC, a global healthcare company specializing in plasma-derived medicines and pharmaceutical supplies. The contract, valued at $126,209.77, is for the procurement of PROLASTIN LIQUID, a medication used to treat alpha1-antitrypsin deficiency. The contract is a firm fixed-price delivery order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Veterans Integrated Service Network 20 (VISN 20), a...
This federal contract award to Grifols USA LLC is for the delivery of PROLASTIN, a plasma-derived medicine used to treat alpha1-antitrypsin deficiency. The contract, valued at $19,304.01, is a delivery order issued under Grifols' Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for Pharmaceuticals and Drugs. As a large business manufacturer of specialized pharmaceutical products, Grifols has extensive experience supplying critical medical supplies to various...